Severity
Moderate
FDA Drug recall · Reported May 17, 2023
Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.
Apotex Corp. recalled Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 20… - a moderate-severity action.
Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 20… was recalled by Apotex Corp. in May 17, 2023. Reason: Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump …. Check the official notice for the remedy. Verify recall #D-0568-2023 with the FDA Drug before acting.
The recall
Apotex Corp. issued this moderate-severity FDA Drug recall-Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump ….
Sourced from official FDA Drug enforcement records. Verify recall #D-0568-2023 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0568-2023) was formally reported on May 17, 2023, with the manufacturer initiating the action on April 26, 2023. It is classified under Moderate severity (Class II), with a current status of Completed. Apotex Corp. is listed as the recalling firm, operating out of Weston, FL. Federal records list the affected scope as 82,375 bottles.
The documented reason for this recall is: Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable. Distribution data in the federal record shows the product reached: Nationwide throughout the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
82,375 bottles
Related Recalls
6
0 from same agency
Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Calcitonin Salmon Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Apotex Corp., Toronto, Ontario, Canada, M9L 1T9, NDC 60505-0823-6
Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Completed |
| Recall number | D-0568-2023 |
| Date reported | May 17, 2023 |
| Date initiated | April 26, 2023 |
| Recalling firm | Apotex Corp. |
| Firm location | Weston, FL |
| Affected scope | 82,375 bottles |
| Distribution | Nationwide throughout the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 17, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.